✦ LIBER ✦

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

✍ Scribed by Meredith M Regan; Patrick Neven; Anita Giobbie-Hurder; Aron Goldhirsch; Bent Ejlertsen; Louis Mauriac; John F Forbes; Ian Smith; István Láng; Andrew Wardley; Manuela Rabaglio; Karen N Price; Richard D Gelber; Alan S Coates; Beat Thürlimann

Book ID: 117785802
Publisher: The Lancet
Year: 2011
Tongue: English
Weight: 287 KB
Volume: 12
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(11)70270-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5016 POSTER DISCUSSION BIG 1-98 Update:

5016 POSTER DISCUSSION BIG 1-98 Update: Evaluating Letrozole and Tamoxifen Alone and in Sequence at 8 Years Median Follow-up for Postmenopausal Women With Steroid Hormone Receptor-Positive Breast Cancer

✍ Gelber, R.D.; Thiirlimann, B.; Giobbie-Hurder, A.; Mauriac, L.; Ejlertsen, B.; P 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Interpreting breast international group

Interpreting breast international group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer

✍ Meredith M Regan; Karen N Price; Anita Giobbie-Hurder; Beat Thürlimann; Richard 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 368 KB